高等学校化学学报 ›› 2015, Vol. 36 ›› Issue (3): 469.doi: 10.7503/cjcu20140907

• 有机化学 • 上一篇    下一篇

新型1,2,4-三唑并[3,4-b]-1,3,4-噻二唑类化合物的合成、 抗菌活性及与FabⅠ作用的分子模拟

王美君, 卢俊瑞(), 辛春伟, 刘金彪, 穆江蓓, 张贺, 张瑞波, 杨旭云, 王宏韫   

  1. 天津理工大学化学化工学院, 天津 300384
  • 收稿日期:2014-10-11 出版日期:2015-03-10 发布日期:2015-01-30
  • 作者简介:联系人简介: 卢俊瑞, 男, 博士, 教授, 博士生导师, 主要从事生物活性化合物分子设计及靶向药物创制研究. E-mail:lujunrui@tjut.edu.cn
  • 基金资助:
    国家自然科学基金(批准号: 21176194, 21476174)资助

Synthesis, Antibacterial Activity and Molecular Simulation with FabⅠ of a Series of Novel 1,2,4-Triazolo[3,4-b]-1,3,4-thiadiazoles

WANG Meijun, LU Junrui*(), XIN Chunwei, LIU Jinbiao, MU Jiangbei, ZHANG He, ZHANG Ruibo, YANG Xuyun, WANG Hongyun   

  1. School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin 300384, China
  • Received:2014-10-11 Online:2015-03-10 Published:2015-01-30
  • Contact: LU Junrui E-mail:lujunrui@tjut.edu.cn
  • Supported by:
    † Supported by the National Natural Science Foundation of China(Nos.21176194, 21476174)

摘要:

以3-芳基/烷基-4-氨基-5-巯基-1,2,4-三唑为原料, 经过环化和糖化反应, 设计合成了10个未见报道的化合物3-芳基/烷基-6-S-2',3',4',6'-四-O-乙酰基-β-D-吡喃葡萄糖基-1,2,4-三唑并[3,4-b]-1,3,4-噻二唑(3a~3j), 其结构经核磁共振波谱、 高分辨质谱和红外光谱确认. 生物活性测试表明, 所有化合物均对大肠杆菌、 金黄色葡萄球菌、 枯草芽孢杆菌和白色念株菌表现出一定的抗菌活性, 其中化合物3c对4种测试菌株的最小抑菌浓度(MIC)最低, 且接近于氟康唑的参照数据, 具有较强的抗菌活性. 利用AutoDock 4.0程序研究了目标化合物3a~3j与大肠杆菌FabⅠ受体蛋白分子的相互作用和结合自由能变化规律.

关键词: 糖苷, 1,2,4-三唑并[3,4-b]-1,3,4-噻二唑, 抗菌活性, FabⅠ受体蛋白

Abstract:

Ten novel compounds of 3-alkyl/aryl-6-S-(2',3',4',6'-tetra-O-acetyl-β-D-glcopyranosyl)-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles were designed and synthesized from 3-alkyl/aryl-4-amino-5-mercapto-1,2,4-triazoles. The structures of all the compounds were confirmed by means of 1H NMR, 13C NMR, HRMS and IR. The preliminary bioassay showed that all target compounds possessed efficient antibacterial activities on Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Monilia albican. Especially, the compound 3c had strong antibacterial by the lowest minimal inhibitory concentration(MIC) values on the four tested strains which were close to those of the controlled drug fluconazole. The interaction and binding free energy of the target compounds(3a—3j) with FabⅠ were studied by AutoDock 4.0.

Key words: Glucoside, 1,2,4-Triazolo[3,4-b]-1,3,4-thiadiazole, Antibacterial, FabⅠ

中图分类号: 

TrendMD: